GK Wealth Management’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$313K Buy
+5,429
New +$312K 0.16% 148
2026
Q1
Sell
-5,234
Closed -$282K 71
2025
Q4
$282K Sell
5,234
-457
-8% -$22K 0.19% 130
2025
Q3
$257K Buy
5,691
+757
+15% +$35.4K 0.19% 135
2025
Q2
$228K Buy
4,934
+972
+25% +$47.7K 0.21% 129
2025
Q1
$242K Sell
3,962
-92
-2% -$5.36K 0.28% 109
2024
Q4
$229K Buy
+4,054
New +$227K 0.29% 108

Other funds holding BMY

GK Wealth Management's BMY Position: Q2 2026 in Review

GK Wealth Management opened a new position in Bristol-Myers Squibb (BMY) in Q2 2026: 5,429 shares worth $313K. The stake represents 0.16% of the portfolio and ranks #148 among its holdings. This is a return to the name: GK Wealth Management previously reported a position in BMY as recently as Q4 2025.

GK Wealth Management first reported a position in BMY in Q4 2024 and has held it in 6 quarters since. 440 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • GK Wealth Management held 5,429 shares of Bristol-Myers Squibb worth $313K as of Q2 2026.
  • Bristol-Myers Squibb was a new GK Wealth Management position in Q2 2026.
  • Bristol-Myers Squibb made up 0.16% of GK Wealth Management's portfolio in Q2 2026, its #148 holding.
  • GK Wealth Management first reported a position in Bristol-Myers Squibb in Q4 2024 and has held it in 6 quarters since.
  • 440 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on GK Wealth Management's 13F filing for Q2 2026, filed 7 Jul 2026.